Registry

Module Specifications

Archived Version 2023 - 2024

Module Title
Module Code
School
Online Module Resources
NFQ level	9	Credit Rating	5
Pre-requisite	None
Co-requisite	None
Compatibles	None
Incompatibles	None

Description

In this module students will study key immunological and molecular pathways involved in immune disorders and cancer. The students will then be introduced to the scientific process that leads to the identification of targets for the development of novel therapeutics including introduction to emerging technologies. Importantly the students will further develop their critical thinking skills by studying examples of successful and disastrous novel therapeutic development cycles. This module is paired with a patient focused workshop during which students will have the opportunity to interact with patients and hear their experiences and impact that novel therapeutics have made in their quality of life. This will be an interactive module with the introduction of case based learning and live polling applications.

Learning Outcomes

1. Systematic understanding of mechanisms of pathology in immune disorders and cancer
2. Critical awareness of how novel therapeutics alter molecular pathways in immune disorders and cancer, focusing on the impact to the patient.
3. Appreciate the emerging need for targeted therapeutics, improved patient stratification and precision medicine
4. Study examples of successful and disastrous therapeutic development in order to enhance critical thinking and assessment of risk.
5. Introduce emerging technologies (for example, artificial intelligence) and interdisciplinarity that accelerate the development of novel therapeutics.

*Type*	*Hours*	*Description*
Workload	Full-time hours per semester
Workshop	2	One interactive workshop with patients and patient advocacy group representatives in order for students to appreciate the impact of novel therapeutic development
Lecture	12	In-person lecture
Tutorial	10	In-person Tutorial
Independent Study	99	Reference to reading material
Assignment Completion	2	No Description
Workshop	2	No Description
Lecture	12	No Description
Tutorial	10	No Description
Independent Study	99	No Description
Assignment Completion	2	No Description
Total Workload: 250

All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml

Indicative Content and Learning Activities

Immuno- and Onco-therapeutics
Introduction to Inflammatory and Autoimmune Diseases; Introduction to Cancer; Introduction to Precision Medicine; Clinical Trials in the Precision Medicine era; Targeted Therapeutics for Inflammatory Diseases, Inherited Diseases and Cancer; Development of novel therapeutics for Inflammatory Diseases, Inherited Diseases and Cancer

Assessment Breakdown
Continuous Assessment	%	Examination Weight	%

Type	Description	% of total	Assessment Date
Course Work Breakdown

Reassessment Requirement
Resit arrangements are explained by the following categories; 1 = A resit is available for all components of the module 2 = No resit is available for 100% continuous assessment module 3 = No resit is available for the continuous assessment component
Unavailable

Indicative Reading List

Francesco Pezzella,Mahvash Tavassoli,David Kerr: 2019, Oxford Textbook of Cancer Biology, Oxford University Press, 9780198779452
Hans-Peter Deigner,Matthias Kohl: 2018, Precision Medicine, Academic Press, 9780128053645
Robert R. Rich: 2012, Clinical Immunology: Principles and Practice by Robert R. Rich, 9780723436911

Other Resources

None

Programme or List of Programmes

Archives: